aspsirna2117 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna2117
siRNA Name: 9
Gene:K-RAS (KRAS)
Disease:Cancer
Wild allele/target (5'->3'): UGUGGUAGUUGGAGCUGGU
Mutant allele/target (5'->3'):UGUGGUAGUUGGAGCUGUU
Target Mutation: c.35G>T,p.Gly12Val
Wild siRNA (As strand):ACACCAUCAACCUCGACCA
ASP-siRNA (As strand):ACACCAUCAACCUCGACAA
Mismatch position in siRNA: A2C
Mutant allele (5'->3'): UGUGGUAGUUGGAGCUGUU
ASP-siRNA (As strand):ACACCAUCAACCUCGACAA
ASP-siRNA efficacy for mutant allele:20
Wild allele (5'->3'): UGUGGUAGUUGGAGCUGGU
ASP-siRNA (As strand):ACACCAUCAACCUCGACAA
ASP-siRNA efficacy for wild allele:5
Percentage discrimination for ASP-siRNA:15
Wild allele (5'->3'): UGUGGUAGUUGGAGCUGGU
Wild siRNA (As strand):ACACCAUCAACCUCGACCA
Wild sirna efficacy for wild allele:67
Wild allele (5'->3'): UGUGGUAGUUGGAGCUGGU
ASP-siRNA (As strand):ACACCAUCAACCUCGACAA
Wild sirna efficacy for mutant allele:23
Percentage discrimination for wild siRNA:44
Concentration:100nM
Orientation:Sense
Mismatch in:siRNA
UniProt ID: P01116
Target sequence: gaatataaacttgtggtagttggagctggtggcgtaggcaagagtgccttgacgatacagctaattcagaatcattt
Genbank Accesion: NM_033360.3
Cell-line: HeLa
Experimental technique used: Dual luciferase reporter assay
Transfection method: Lipofectamine 2000
siRNA expression method: Dharmacon
Post-transfection duration: 24 hours
OMID ID: 190070
KEGG disease ID:H00003
Reference:US2005/0176045A1

.
.
.
.
.
.
.
.
.
.
.

.

.

.